Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 964

1.

Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.

Mahesh R, Perumal RV, Pandi PV.

Pharmazie. 2005 Feb;60(2):83-96. Review.

PMID:
15739895
2.

Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.

Navari RM.

J Support Oncol. 2003 Jul-Aug;1(2):89-103. Review.

PMID:
15352652
3.

Anti-emetic therapy in cancer chemotherapy: current status.

Herrstedt J, Dombernowsky P.

Basic Clin Pharmacol Toxicol. 2007 Sep;101(3):143-50. Review.

4.

[Recent improvements in antiemetic therapy].

Roila F, Palladino MA, Ciccarese G, Basurto C.

Tumori. 1997;83(2 Suppl):S3-14. Review. Italian.

PMID:
9235727
5.
6.

Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.

Hesketh PJ.

Support Care Cancer. 2001 Jul;9(5):350-4. Review.

PMID:
11497388
7.

5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.

Cunningham RS.

Oncol Nurs Forum. 1997 Aug;24(7 Suppl):33-40. Review.

PMID:
9282379
8.

Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.

Herrstedt J.

Expert Opin Drug Saf. 2004 May;3(3):231-48. Review.

PMID:
15155151
9.

[Prophylaxis of chemotherapy-induced vomiting and nausea].

Tóth J, Szántó J.

Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Review. Hungarian.

PMID:
19068468
10.
11.

Clinical practice guidelines on antiemetics in oncology.

Aranda Aguilar E, Constenla Figueiras M, Cortes-Funes H, Diaz-Rubio García E, Gascon Vilaplana P, Guillém V, Martin-Algarra S.

Expert Rev Anticancer Ther. 2005 Dec;5(6):963-72. Review.

PMID:
16336087
12.

Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.

Jordan K, Kasper C, Schmoll HJ.

Eur J Cancer. 2005 Jan;41(2):199-205. Review.

PMID:
15661543
13.

Pharmacological agents affecting emesis. A review (Part I).

Mitchelson F.

Drugs. 1992 Mar;43(3):295-315. Review.

PMID:
1374316
14.

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.

Celio L, Denaro A, Canova S, Gevorgyan A, Bajetta E.

Tumori. 2008 Jul-Aug;94(4):447-52. Review.

15.
16.

[New developments in the treatment of nausea and vomiting caused by chemotherapy].

de Wit R, van Alphen MM.

Ned Tijdschr Geneeskd. 2003 Apr 12;147(15):690-4. Review. Dutch.

PMID:
12722531
17.
18.

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.

Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, Julie Ma G, Eldridge K, Hipple A, Evans JK, Horgan KJ, Lawson F; Aprepitant Protocol 054 Study Group.

Cancer. 2003 Jun 15;97(12):3090-8.

19.
20.

Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?

Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A.

J Oncol Pharm Pract. 2007 Jun;13(2):69-75.

PMID:
17873106

Supplemental Content

Support Center